YISSUM RESEARCH DEVELOPMENT COMPANY;CELSUS THERAPEUTICS PLC
发明人:
SHAUL YEDGAR,YUVAL COHEN
申请号：
US14478519
公开号：
US20150065467A1
申请日:
2014.09.05
申请国别(地区):
US
年份:
2015
代理人:
摘要：
In one embodiment, the invention provides a method of treating, reducing the incidence, reducing the severity or pathogenesis of an eye disease or disorder in a subject, including, inter alia, retinal detachment, macular degeneration, glaucoma or retinopathy, comprising the step of administering an effective amount of a lipid or phospholipid moiety bound optionally via a spacer to a physiologically acceptable monomer, dimer, oligomer, or polymer via an ester or amide bond, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof. This invention also provides a contact lens solution comprising a lipid or phospholipid moiety bound optionally via a spacer to a physiologically acceptable monomer, dimer, oligomer, or polymer via an ester or amide bond, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof.
